Stone House Investment Management’s Soleno Therapeutics SLNO Stock Holding History

Stone House Investment Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51	Closed	-$1.71K	–	1406
2026 Q1	$1.71K	Buy	51 +50	+5,000%	+$1.96K	﹤0.01%	619
2025 Q4	$46	Sell	1 -26	-96%	-$1.43K	﹤0.01%	840
2025 Q3	$1.82K	Buy	+27	New	+$2K	﹤0.01%	499

Stone House Investment Management's SLNO Position: Q2 2026 in Review

Stone House Investment Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 51 shares — an estimated $1.71K sold.

Stone House Investment Management first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $1.82K in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Stone House Investment Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Stone House Investment Management sold 51 Soleno Therapeutics shares in Q2 2026, an estimated $1.71K.
Stone House Investment Management first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
Stone House Investment Management's Soleno Therapeutics position peaked at $1.82K in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.